[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 1,068
Citations 0
Correction
September 13, 2016

Incorrect Test Characteristic

JAMA. 2016;316(10):1116. doi:10.1001/jama.2016.10856

In the JAMA Diagnostic Test Interpretation entitled “Elevated Hemoglobin or Hematocrit Level,”1 published in the May 24/31, 2016, issue of JAMA, a test characteristic was incorrectly described. The sentence that read as follows: “Typically, JAK2V617F is quantitatively reported as picogram of JAK2V617F per microliter of plasma (Medicare reimbursement cost of testing, $124.87), although qualitative tests are available.” should have read in the following way: “Typically, JAK2V617F is quantitatively reported as a percentage of extracted genomic DNA found to have the point mutation causing JAK2V617F (Medicare reimbursement cost of testing, $124.87), although qualitative tests are available.” This article was corrected online.

References
1.
Scherber  RM, Mesa  RA.  Elevated hemoglobin or hematocrit level.  JAMA. doi:10.1001/jama.2016.2435.
×